See inside every stock. Pro
S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI99.73▲ 2.66%
← 0P2W page
XStocksXray
Market X-Ray report · 21 October 2026

Amadeus IT (0P2W)

London Exchange · UK · prices in EUR · close of 21 Oct 2026

Key indicators

Last closeEUR 55.84
52-week range45.27 – 67.54
Return, 1 month / 3 months+1.6% / +15.2%
Return, 1 year / 3 years−16.7% / +9.6%
TrendUptrend
RSI (14)62
Volatility (1 year)30.3%
Worst drawdown (1 year)-31.2%
Average daily value traded6.93M EUR
Dividend yield2.2%

Market X-Ray price-based

58/ 100 · High confidence · ahead of 59% of stocks on this exchange
Trend60
Momentum60
Stability (higher is calmer)54
Liquidity71
Income36

Five-year price chart navy: price · brown: 200-day average

40.8949.3057.7066.1074.502021-102023-012024-042025-072026-10

About the company

Amadeus IT Group is a technology company serving the travel and tourism industry. It operates a global distribution system that travel agencies use to book airline seats, hotel rooms and other travel services, and it supplies airlines with reservation and inventory management systems. It also provides technology for airports, hotels and rail operators. The company is based in Spain and serves customers across the world.

Amadeus IT trades under the code 0P2W on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Amadeus IT (0P2W) trades on the London Exchange in UK. It last closed at EUR 55.84 on 21 October 2026.

Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,553 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 16.7% and over the last three months it rose 15.2%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Amadeus IT (0P2W)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend60 · FairMixed trend against its averages.
Above 200-day average6.2%
From 52-week high-16.7%
Momentum60 · FairTypical recent returns for this exchange.
3-month return15.2%
6-month return13.9%
12-month return, skipping the last month-18.1%
Stability (higher is calmer)54 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)30.3%
Worst drawdown, 1 year (smaller is calmer)-31.2%
Liquidity71 · StrongTrades actively.
Average daily value traded6.93M EUR
Zero-volume days0.0%
Income36 · WeakDividend is small or irregular.
Dividend yield2.2%
Years with dividends4

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week+6.2%
1 month+1.6%
3 months+15.2%
6 months+13.9%
1 year−16.7%
3 years+9.6%
5 years+7.9%

Signals

50-day / 200-day average55.05 / 52.57
Golden / death cross (60 days)Golden, 32 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.24

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyBullish8 bullish · 1 neutral · 3 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

Recent dividends

Ex-dividend dateAmount per share
1 Jul 2026EUR 0.8181
14 Jan 2026EUR 0.4293
2 Jul 2025EUR 0.7209
15 Jan 2025EUR 0.4050
2 Jul 2024EUR 0.6480
16 Jan 2024EUR 0.3564

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 22 Oct 2026